Product NDC: | 65862-168 |
Proprietary Name: | Atenolol |
Non Proprietary Name: | Atenolol |
Active Ingredient(s): | 25 mg/1 & nbsp; Atenolol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-168 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078512 |
Marketing Category: | ANDA |
Start Marketing Date: | 20071031 |
Package NDC: | 65862-168-01 |
Package Description: | 100 TABLET in 1 BOTTLE (65862-168-01) |
NDC Code | 65862-168-01 |
Proprietary Name | Atenolol |
Package Description | 100 TABLET in 1 BOTTLE (65862-168-01) |
Product NDC | 65862-168 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Atenolol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20071031 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | ATENOLOL |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |